Revance Therapeutics
RVNC
₹312.16
Share price
0.00%
Change (1 day)
-17.71%
Change (1 year)
Categories
Revance Therapeutics (RVNC) - Cash on Hand
Cash on Hand as of September 2024 : ₹15.74 Billion
According to Revance Therapeutics's latest financial reports the company has ₹15.74 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Revance Therapeutics - Cash on Hand chart (from 2012 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | ₹21.13 B | -25.02% |
| 2022-12-31 | ₹28.19 B | 68.3% |
| 2021-12-31 | ₹16.75 B | -47.52% |
| 2020-12-31 | ₹31.92 B | 54.31% |
| 2019-12-31 | ₹20.68 B | 68.29% |
| 2018-12-31 | ₹12.29 B | -31.94% |
| 2017-12-31 | ₹18.06 B | 43.27% |
| 2016-12-31 | ₹12.60 B | -24.81% |
| 2015-12-31 | ₹16.76 B | 54.68% |
| 2014-12-31 | ₹10.83 B | 4382.78% |
| 2013-12-31 | ₹0.24 B | 8.16% |
| 2012-12-31 | ₹0.22 B | -85.73% |
| 2011-12-31 | ₹1.56 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | ₹3.45 B | -78.07% | 🇺🇸 USA |
 | ₹2.097 T | 13,221.67% | 🇺🇸 USA |
 | ₹203.11 B | 1,190.23% | 🇺🇸 USA |